Skip to main content
LUMIBIRD logo

LUMIBIRD — Investor Relations & Filings

Ticker · LBIRD ISIN · FR0000038242 LEI · 969500MLJC3ZSZP4L019 PA Manufacturing
Open in API
Filings indexed 560 across all filing types
Latest filing 2024-05-03 Regulatory Filings
Country FR France
Listing PA LBIRD

About LUMIBIRD

https://www.lumibird.com/en/

LUMIBIRD is a leading specialist in laser technologies with over 50 years of experience. The company designs and manufactures high-performance lasers based on its expertise in three key technologies: solid-state lasers, fiber lasers, and laser diodes. It operates through two primary divisions. The Photonics division provides advanced laser solutions for applications in defense, space, environmental monitoring (including Lidar sensors), industrial manufacturing, and scientific research. The Medical division offers innovative ophthalmological and medical solutions, ranging from diagnostic equipment to laser treatment systems, through brands such as Quantel Medical and Ellex.

Recent filings

Filing Released Lang Actions
LUMIBIRD MEDICAL OBTIENT LE MARQUAGE CE POUR LE C.DIAG®, PLATEFORME D’AIDE AU DIAGNOSTIC DE LA SECHERESSE OCULAIRE
Regulatory Filings Classification · 95% confidence The document is a press release dated May 3, 2024, announcing that LUMIBIRD MEDICAL has obtained the CE marking for its C.DIAG® platform for diagnosing dry eye disease. It details product launch, market size, and strategic positioning. Crucially, it concludes with a section titled "Prochain rendez-vous : Capital Market Day, le 21/05/2024". This structure—a significant business update followed by an announcement of an upcoming investor event—is characteristic of a general corporate announcement or press release that doesn't fit the specific financial report categories (like 10-K, IR, ER). Since it is a formal announcement of a business milestone and market update, and it is not a transcript (CT), a formal financial report (IR/10-K), or a pure earnings release (ER), it best fits the general Regulatory Filings (RNS) category, which serves as a broad category for official company news releases that aren't covered elsewhere. The document length (5501 chars) is substantial enough that it is not just a brief 'Report Publication Announcement' (RPA).
2024-05-03 French
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE
Regulatory Filings Classification · 100% confidence The document is a press release dated May 3, 2024, announcing that LUMIBIRD MEDICAL has obtained CE Marking for its C.DIAG® platform and is launching the product. It details product features, market size, and strategic goals. It concludes with a notice for the 'Next date: Capital Market Day, 21/05/2024'. This type of announcement, which is a formal communication about a significant business event (product launch/regulatory approval) but is not a full financial report (like 10-K or IR) or a transcript, most closely aligns with a general regulatory announcement or press release. Since 'Regulatory Filings' (RNS) is the fallback for miscellaneous announcements that don't fit specific financial reporting categories, and this is a news release about a business development, RNS is the most appropriate classification. It is not an Earnings Release (ER) as it doesn't focus on period results, nor is it an Investor Presentation (IP) or Management Discussion (MDA).
2024-05-03 English
LUMIBIRD : CROISSANCE DE 7,5% AU 1er TRIMESTRE 2024
Earnings Release Classification · 100% confidence The document is a press release from Lumibird announcing its financial results for the first quarter of 2024. It provides key highlights, revenue figures, segment breakdowns, and outlook, which fits the definition of an Earnings Release (ER). It is not a full quarterly report (IR) as it is a summary announcement, and it is not a report publication announcement (RPA) because it contains the actual financial data rather than just notifying of a report's availability. Q1 2024
2024-04-22 French
LUMIBIRD: 7.5% GROWTH FOR THE FIRST QUARTER OF 2024
Earnings Release Classification · 99% confidence The document presents consolidated revenues for the first quarter of 2024 (€43.9m, up 7.5%), detailing performance by market segment (Photonics, Medical) and geography. It includes unaudited data, segment breakdowns, and an outlook confirming the organic growth target for 2024. This structure—a summary of financial results for a period shorter than a year (Q1)—is characteristic of an Interim/Quarterly Report. Although it contains highlights, the level of detail (tables, segment analysis) suggests it is more comprehensive than a simple Earnings Release (ER). It is not a full Annual Report (10-K) as it only covers Q1. It is not an RPA because it is the actual financial summary, not just an announcement of its publication. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). Q1 2024
2024-04-22 English
LUMIBIRD : nombre d'actions au 31 mars 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (839 characters) and presents a table titled 'Informations relatives au nombre total de droits de vote et d'actions' (Information relating to the total number of voting rights and shares). It explicitly references French regulatory articles (Code de commerce and AMF General Regulation) and provides a snapshot of the total number of shares and voting rights as of March 31, 2024. This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing requirement, often related to capital structure updates or general compliance announcements. Given the options, it is a specific regulatory disclosure that doesn't fit perfectly into the main financial reports (10-K, IR) or specific events (DIV, DIRS). It is most closely aligned with a general regulatory announcement or a specific capital/share structure update. Since it details the total number of shares and voting rights, it falls under the scope of capital structure information. However, it is not a formal share issue (SHA) or transaction (POS), but rather a periodic disclosure of the total count. In the context of French regulations, these disclosures are mandatory periodic reports. Given the available codes, 'SHA' (Share Issue/Capital Change) is related to capital structure, but 'RNS' (Regulatory Filings) is the best fallback for specific, non-standard regulatory disclosures. Since it is a direct disclosure of the total share count, which impacts capital structure, and it is not an announcement of a transaction or issuance, I will classify it as a specific regulatory filing (RNS) as it is a mandatory compliance disclosure that doesn't fit the other specific categories like DIV, DIRS, or SHA (which implies an action). The short length also suggests it's not a comprehensive report.
2024-04-08 French
LUMIBIRD : DOCUMENT D’ENREGISTREMENT UNIVERSEL 2023
Annual Report Classification · 100% confidence The document is titled 'Document d’Enregistrement Universel 2023' and is filed with the AMF (Autorité des marchés financiers) as per EU regulation 2017/1129. It contains comprehensive sections including group presentation, governance, risk and control, financial elements with management report, social and consolidated accounts for the fiscal year ended 31/12/2023, auditor reports on these accounts, extra-financial performance declarations, and information related to the upcoming Annual General Meeting. The document is extensive (15,000 characters) and includes detailed financial statements and management discussion. This matches the characteristics of an Annual Report (10-K equivalent) which covers full company activity and financial performance for the year. It is not a mere announcement or certification, but a full report. Therefore, the correct classification is Annual Report (10-K). FY 2023
2024-04-05 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.